CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 39 filers reported holding CYTOSORBENTS CORP in Q4 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $70,000 | -93.1% | 22,524 | -80.9% | 0.00% | – |
| Q3 2021 | $1,010,000 | +6633.3% | 117,966 | +6847.3% | 0.00% | – |
| Q1 2021 | $15,000 | -75.8% | 1,698 | -75.4% | 0.00% | – |
| Q4 2020 | $62,000 | +226.3% | 6,898 | +184.1% | 0.00% | – |
| Q3 2020 | $19,000 | -42.4% | 2,428 | -25.9% | 0.00% | – |
| Q2 2020 | $33,000 | +725.0% | 3,278 | +528.0% | 0.00% | – |
| Q1 2020 | $4,000 | -76.5% | 522 | -88.3% | 0.00% | – |
| Q4 2019 | $17,000 | +21.4% | 4,476 | +66.7% | 0.00% | – |
| Q3 2019 | $14,000 | -17.6% | 2,685 | +6.5% | 0.00% | – |
| Q2 2019 | $17,000 | +325.0% | 2,521 | +480.9% | 0.00% | – |
| Q4 2018 | $4,000 | -55.6% | 434 | -35.4% | 0.00% | – |
| Q3 2018 | $9,000 | +350.0% | 672 | +232.7% | 0.00% | – |
| Q2 2018 | $2,000 | -99.3% | 202 | -99.6% | 0.00% | – |
| Q4 2015 | $306,000 | – | 54,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |